What is Tri- Pharma?
Founded on the principle of prioritizing long-term customer, employee, and patient needs, Tri-Pharma Inc. operates as a comprehensive distributor of FDA-approved prescription and over-the-counter pharmaceuticals. Sourced exclusively from FDA-approved manufacturers and Authorized Trading Partners, the company's extensive product selection serves thousands of hospitals, government facilities, and specialty providers nationwide. Tri-Pharma distinguishes itself through its robust operational excellence, leveraging state-of-the-art facility systems for inventory management, shipment tracking, security, and precise environmental controls to ensure product integrity. A significant competitive advantage lies in its rapid nationwide delivery capability, often shipping essential medications within one to two days, facilitated by strategic shipping contracts that translate cost savings to customers. The company upholds a firm ethical code, treating its role in patient care with the highest regard and ensuring service continuity through advanced technology infrastructure with built-in redundancies.
How much funding has Tri- Pharma raised?
Tri- Pharma has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Tri- Pharma?
With the recent influx of capital from its major strategic investment, Tri-Pharma is well-positioned for continued growth and operational expansion. The company's focus on maintaining competitive pricing, ensuring product integrity, and providing rapid nationwide distribution, particularly through its efficient logistics network, will likely be further amplified. This late-stage funding suggests a strategic push to solidify its market leadership in the pharmaceutical supply chain, potentially involving enhancements to its technology infrastructure, expansion of its distribution network, or increased inventory capacity to meet the evolving demands of healthcare facilities. Tri-Pharma's commitment to ethical operations and reliability remains a cornerstone for future development.
See full Tri- Pharma company page
